What is Cryptolepis?

Cryptolepis sanguinolenta is a woody climbing plant native to the tropical rainforests of West and Central Africa, particularly Ghana, Nigeria, and Ivory Coast. Its deep-yellow root bark contains a unique class of alkaloids — most notably cryptolepine — that give the plant its striking color and notable biological activity. It has been a cornerstone of traditional healing in Ghana for generations, used to treat fevers, malaria, respiratory infections, and gastrointestinal illness.

How does Cryptolepis work?

The primary active compound, cryptolepine, is thought to disrupt the DNA of pathogens by inserting itself into their genetic material, potentially interfering with their ability to reproduce. It may also block key enzymes that certain parasites and bacteria depend on for survival. Beyond fighting infections, cryptolepine and related compounds appear to support healthy blood sugar by improving how the body responds to insulin and how the liver manages glucose, though these mechanisms require further investigation in humans.

What forms does Cryptolepis come in?

Root tinctures in alcohol or water-alcohol blends are the most widely used form and preserve the full alkaloid profile well. Capsules of dried root powder are more convenient but may deliver less bioavailable alkaloids. Root tea (decoction) is the traditional preparation in Ghana and remains effective. Liquid extracts standardized to cryptolepine content are the most consistent option for therapeutic use.

Where it comes from:

Cryptolepis has been used in Ghanaian traditional medicine for at least several hundred years under the name 'nibima.' It gained international scientific attention in the 1980s and 1990s when researchers began isolating its alkaloids and investigating its antimalarial activity. It has since attracted interest in the Western integrative medicine community, particularly for its potential role in Lyme disease and tick-borne co-infections, where it is used alongside other herbs in protocols developed by integrative practitioners.

What does Cryptolepis help with?

• Malaria: Cryptolepis has been traditionally used in West Africa — particularly Ghana — as a primary remedy for malaria. The main alkaloid, cryptolepine, is thought to kill the malaria parasite by interfering with its ability to replicate DNA. It is traditionally regarded in Ghana as helping to clear uncomplicated malaria, though the evidence base remains limited and it has not been rigorously validated against modern clinical trial standards. It is among the more studied traditional herbal antimalarials in the region.
• Lyme disease and tick-borne infections: Cryptolepine is thought to be active against Borrelia burgdorferi — the bacteria behind Lyme disease — including dormant forms that may contribute to persistent symptoms. It is traditionally used in some integrative Lyme protocols, often paired with other antimicrobial herbs. Human clinical trials specific to Lyme disease have not been conducted, so its use in this context remains observational and speculative.
• Babesiosis: Babesia is a malaria-like parasite transmitted by ticks, and cryptolepis is traditionally used in some integrative medicine contexts for this co-infection. Its antiparasitic activity is thought to extend to this organism, and some practitioners report using it in this context, though formal clinical trials in humans with babesiosis have not been published. Its use here remains observational.
• High blood sugar and type 2 diabetes: Cryptolepis has been traditionally used in West Africa for conditions associated with excessive thirst and urination, and it is traditionally regarded as helping the body use insulin more effectively and slowing carbohydrate absorption after meals. Some early, small-scale human observations from Ghana have noted reductions in blood sugar levels, but the evidence is preliminary and insufficient to draw firm conclusions. It should not replace established diabetes management.
• Urinary tract infections (UTIs): Cryptolepis has traditionally been used for urinary complaints in West Africa, and it is traditionally credited with antibacterial activity against common UTI-causing organisms, including E. coli. Dedicated clinical trials for UTIs in humans have not been conducted, so its use in this area is supported by traditional practice and preliminary lab findings rather than verified clinical evidence.
• MRSA and antibiotic-resistant bacteria: Cryptolepis alkaloids are thought to inhibit methicillin-resistant Staphylococcus aureus (MRSA) and other resistant strains, an idea that has generated interest in the research community. These findings have not been tested in human clinical trials, so any use in managing resistant bacterial infections remains speculative and observational at this stage.
• Fever and general infections: Traditional use of cryptolepis for fever is well-established across West African healing traditions, and the plant's antimicrobial and anti-inflammatory properties are thought to provide a plausible basis for this application. It is traditionally prepared as a root tea at the first sign of fever or infection in West African communities and remains one of the most widely trusted traditional fever remedies in the region.
• Gastrointestinal infections: Cryptolepis has long been used traditionally for diarrhea and intestinal infections across West Africa, and it is traditionally credited with activity against several gut pathogens. The combination of possible antibacterial and anti-inflammatory properties is thought to contribute to its traditional use for gastroenteritis-type symptoms, though human clinical evidence is lacking.
• Inflammation and pain: Several alkaloids in cryptolepis are thought to have anti-inflammatory effects, involving reducing the production of inflammatory signaling molecules. This provides a plausible basis for its traditional use in addressing general pain and inflammatory conditions, though human clinical evidence for this application is lacking and more limited than even its preliminary antimicrobial data.

What can Cryptolepis help prevent?

• Malaria recurrence (used as prophylactic in traditional West African medicine, supported by antimalarial mechanism)
• Antibiotic-resistant infection progression (traditionally credited with activity against resistant strains)

Which foods are rich in Cryptolepis?

Cryptolepis is not found in any common foods — it is a specific West African medicinal plant used only as an herbal preparation. To support the same goals (fighting infection, stabilizing blood sugar, reducing inflammation), focus on: bitter foods like dandelion greens and bitter melon, which support liver and blood sugar function similarly; garlic and oregano, which provide broad-spectrum antimicrobial support; leafy greens and colorful vegetables, which help regulate blood sugar and reduce inflammation; fermented foods like kefir and kimchi, which support the gut microbiome during and after antimicrobial treatment; and berberine-containing foods like barberry, which overlap with cryptolepis on both blood sugar and antimicrobial pathways. Avoid high-sugar foods and refined carbohydrates during any infection or blood sugar management protocol, as they can fuel pathogens and blunt treatment response.

What are the side effects of Cryptolepis?

• Nausea or stomach upset (most common, especially on an empty stomach)
• Dizziness or lightheadedness (at higher doses)
• Sedation or drowsiness (dose-dependent, related to cryptolepine's CNS activity)
• Low blood sugar symptoms (shakiness, fatigue) if combined with diabetes medication
• Yellow discoloration of urine or skin (harmless, from the yellow alkaloids — similar to turmeric)
• Loose stools or mild diarrhea (at higher doses or early in treatment)
• Not recommended during pregnancy or breastfeeding (insufficient safety data)

Good to know:

Cryptolepis is generally well-tolerated when used at recommended doses and for defined treatment periods. Most reported side effects are mild and dose-dependent. The safety record in traditional West African use is long, but it is not recommended during pregnancy or for extended unsupervised use at high doses.

How much Cryptolepis should you take?

• Recommended daily: Tincture (1:5 in 60% alcohol): 3–5 mL, 3 times daily. Dried root capsules: 1,000–1,500 mg, 2–3 times daily. Root tea (decoction): 1–2 teaspoons of dried root per cup, simmered 15–20 minutes, 2–3 cups daily.
• Best time of day: Spread doses evenly throughout the day (morning, midday, and evening) to maintain steady levels of active alkaloids in the body.
• With or without food: Take with food or shortly after eating to reduce the chance of nausea. Avoid taking on a completely empty stomach.
• Time to effect: Acute infections: 3–7 days. Chronic infections such as Lyme: 4–8 weeks of consistent use typically required.
• How long to take it: For acute infections (malaria, UTI): 7–14 days. For chronic infections (Lyme protocol): typically used in 4–8 week courses followed by a 1–2 week break, then reassessed. Not recommended for indefinite continuous use without practitioner guidance.